Pharmaceuticals & Biotechnology

Voyager Therapeutics, Inc. CEO pay

Alfred Sandrock, M.D., Ph.D. Chief Executive Officer, President, and Director. Fiscal year 2025, as reported to the SEC.

Total compensation

$2.5M

$2,508,370 for fiscal 2025: the Summary Compensation Table total, with stock and option awards at their grant-date value.

Definitive proxy statement, filed 2026-04-28SEC accession number 0001104659-26-050297

In context

The median chief executive among 248 Pharmaceuticals & Biotechnology companies with under $100M in revenue was paid $1.6M. The middle half ranged from $694K to $3.3M.

Alfred Sandrock's total is above that median.

See how your pay compares to Voyager Therapeutics, Inc.'s peers

CEOSalary breaks this total into salary, bonus, stock and option awards, builds a peer set of comparable companies around it, and places your own package against them, with every figure cited to its filing.

Start a 3-day trial

Source: Voyager Therapeutics, Inc.'s definitive proxy statement (SEC Form DEF 14A), Summary Compensation Table, fiscal year 2025. Figures are as reported by the company and are not adjusted or estimated. Context figures are from CEOSalary's snapshot of SEC filings as of 2026-10-28. Not financial, legal or compensation-consulting advice.